J. Dana Hughes
Originally from Boston, Massachusetts, Dana has been based in New York City since 1996. Dana Hughes is currently Transactions Strategy Leader, Life Sciences, at KPMG. He serves medical device, biopharmaceuticals and biotechs in executing acquisitions, carve-outs and partnerships. He had been a Partner at the Boston Consulting Group (BCG), and before that Dana was Vice President in Pfizer’s Worldwide Business Development group, serving as its Global Head for Integration Management and Global Head of Alliance Management. His work included the integration of Wyeth, Hospira, Anacor, Medivation, Therachon, Array and most recently Amplyx. He also directly led the separation of Upjohn (creating Viatris), Pfizer Consumer Healthcare (into the Haleon joint venture with GSK), Hospira Infusion Systems and the creation of independent companies such as Zoetis (former Pfizer Animal Health) and Allogene (former Pfizer CAR-T portfolio). Prior to BCG and Pfizer, Dana advised multi-industry businesses with Lazard Frères & Co’s mergers and acquisitions group. Dana received his Bachelor’s of Arts in Classical Archaeology from Harvard University, with an ICCS Fellowship at the American Academy in Rome. He also holds an MBA in International Finance from Columbia University. Dana lives in Brooklyn with his wife Melissa Prober, an independent attorney for non-profit organizations. He has two children. Dana is on the Board of the Brooklyn Bridge Park Conservancy and is an active user of the park. Originally from Boston, Massachusetts, Dana has been based in New York City since 1996.
Role: Trustee
Elected to the Board: September 2020
Class Term: 2024
Term Limit: 2028